These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21355774)

  • 1. Transurethral ethanol ablation of the prostate for symptomatic benign prostatic hyperplasia: long-term follow-up.
    El-Husseiny T; Buchholz N
    J Endourol; 2011 Mar; 25(3):477-80. PubMed ID: 21355774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transurethral ethanol ablation of the prostate (TEAP): an effective minimally invasive treatment alternative to traditional surgery for symptomatic benign prostatic hyperplasia (BPH) in high-risk comorbidity patients.
    Magno C; Mucciardi G; Galì A; Anastasi G; Inferrera A; Morgia G
    Int Urol Nephrol; 2008; 40(4):941-6. PubMed ID: 18478352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of transurethral ethanol ablation of prostate for symptomatic benign prostatic hyperplasia.
    Faruque MS; Alam MK; Ullah MA; Rahman MH; Kibria MG; Haque MM; Haque MA; Joarder AI; Paul BK
    Mymensingh Med J; 2012 Apr; 21(2):265-9. PubMed ID: 22561769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ultrasound-guided transrectal ethanol injection for the treatment of benign prostatic hyperplasia in patients with high-risk comorbidities: a long-term study at a single tertiary care institution.
    Li Y; Zhao Q; Dong L
    Urology; 2014 Mar; 83(3):586-91. PubMed ID: 24581519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
    Kahn SA; Alphonse P; Tewari A; Narayan P
    J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic hydroablation (Aquablation): A new effective ultrasound guided robotic waterjet ablative surgery for treatment of benign prostatic hyperplasia.
    Lim Ng K; Barber N
    Arch Esp Urol; 2019 Oct; 72(8):786-793. PubMed ID: 31579037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
    Sakr M; Eid A; Shoukry M; Fayed A
    Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
    J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral needle ablation of the prostate: a minimally invasive treatment for symptomatic benign prostatic hyperplasia.
    Beduschi MC; Oesterling JE
    Mayo Clin Proc; 1998 Jul; 73(7):696-701. PubMed ID: 9663202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary results of transurethral prostate ethanol injection.
    Arslan M; Oztürk A; Goger YE; Aslan E; Kilinc M
    Int Urol Nephrol; 2014 Sep; 46(9):1709-13. PubMed ID: 24705726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Woo HH; Chin PT; McNicholas TA; Gill HS; Plante MK; Bruskewitz RC; Roehrborn CG
    BJU Int; 2011 Jul; 108(1):82-8. PubMed ID: 21554526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective multi-center study elucidating patient experience after prostatic urethral lift.
    Shore N; Freedman S; Gange S; Moseley W; Heron S; Tutrone R; Brown T; Barkin J
    Can J Urol; 2014 Feb; 21(1):7094-101. PubMed ID: 24529008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiofrequency method of thermal tissue ablation for benign prostatic hyperplasia.
    Bhanot SM; Grigor KM; Hargreave TB; Chisholm GD
    Urology; 1995 Mar; 45(3):427-33; discussion 433-4. PubMed ID: 7533454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital.
    Malde S; Rajagopalan A; Patel N; Simoes A; Choi W; Shrotri N
    J Endourol; 2012 Jul; 26(7):878-83. PubMed ID: 22260554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.